
Thea D' Ambrosio
Examiner (ID: 2073, Phone: (571)270-1216 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1675, 1654 |
| Total Applications | 599 |
| Issued Applications | 266 |
| Pending Applications | 113 |
| Abandoned Applications | 241 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10968128
[patent_doc_number] => 20140371160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-18
[patent_title] => 'NOVEL ALPHA-1 ANTITRYPSIN VARIANT, PREPARATION METHOD THEREOF AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/344468
[patent_app_country] => US
[patent_app_date] => 2012-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10999
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344468
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/344468 | Alpha-1 antitrypsin variant, preparation method thereof and use thereof | Aug 12, 2012 | Issued |
Array
(
[id] => 8659126
[patent_doc_number] => 20130039954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'CONTROL OF ANTIBODY RESPONSES TO SYNTHETIC NANOCARRIERS'
[patent_app_type] => utility
[patent_app_number] => 13/560925
[patent_app_country] => US
[patent_app_date] => 2012-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23367
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13560925
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/560925 | CONTROL OF ANTIBODY RESPONSES TO SYNTHETIC NANOCARRIERS | Jul 26, 2012 | Abandoned |
Array
(
[id] => 10906157
[patent_doc_number] => 20140309170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-16
[patent_title] => 'ANTI-ANGIOGENIC PEPTIDES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/235563
[patent_app_country] => US
[patent_app_date] => 2012-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 9335
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14235563
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/235563 | ANTI-ANGIOGENIC PEPTIDES AND USES THEREOF | Jul 22, 2012 | Abandoned |
Array
(
[id] => 10025004
[patent_doc_number] => 09066882
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-30
[patent_title] => 'Method and a system for producing thermolabile nanoparticles with controlled properties and nanoparticles matrices made thereby'
[patent_app_type] => utility
[patent_app_number] => 13/554798
[patent_app_country] => US
[patent_app_date] => 2012-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2947
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 269
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13554798
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/554798 | Method and a system for producing thermolabile nanoparticles with controlled properties and nanoparticles matrices made thereby | Jul 19, 2012 | Issued |
Array
(
[id] => 10912768
[patent_doc_number] => 20140315784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'Binding Inhibitors of the Beta. Transducin Repeat-Containing Protein'
[patent_app_type] => utility
[patent_app_number] => 14/127430
[patent_app_country] => US
[patent_app_date] => 2012-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 48144
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14127430
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/127430 | Binding Inhibitors of the Beta. Transducin Repeat-Containing Protein | Jun 26, 2012 | Abandoned |
Array
(
[id] => 13196149
[patent_doc_number] => 10112984
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-30
[patent_title] => Light-sensitive chimeric GPCR protein
[patent_app_type] => utility
[patent_app_number] => 14/128155
[patent_app_country] => US
[patent_app_date] => 2012-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 7054
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14128155
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/128155 | Light-sensitive chimeric GPCR protein | Jun 21, 2012 | Issued |
Array
(
[id] => 9046825
[patent_doc_number] => 08541379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-24
[patent_title] => 'Kokumi-imparting agent'
[patent_app_type] => utility
[patent_app_number] => 13/529482
[patent_app_country] => US
[patent_app_date] => 2012-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12960
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13529482
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/529482 | Kokumi-imparting agent | Jun 20, 2012 | Issued |
Array
(
[id] => 11225347
[patent_doc_number] => 09453062
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-27
[patent_title] => 'Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/125061
[patent_app_country] => US
[patent_app_date] => 2012-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 27365
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 410
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125061
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/125061 | Glucose dependent insulinotropic polypeptide analogs, pharmaceutical compositions and use thereof | Jun 7, 2012 | Issued |
Array
(
[id] => 9643158
[patent_doc_number] => 20140221271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'SHK-BASED PHARMACEUTICAL COMPOSITIONS AND METHODS OF MANUFACTURING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/124669
[patent_app_country] => US
[patent_app_date] => 2012-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12374
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124669
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/124669 | SHK-based pharmaceutical compositions and methods of manufacturing and using the same | Jun 4, 2012 | Issued |
Array
(
[id] => 17843778
[patent_doc_number] => 11433120
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-06
[patent_title] => Controlled release peptide formulations
[patent_app_type] => utility
[patent_app_number] => 14/117994
[patent_app_country] => US
[patent_app_date] => 2012-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16885
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117994
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/117994 | Controlled release peptide formulations | May 24, 2012 | Issued |
| 13/474411 | COMPOSITIONS AND METHODS FOR TREATING HCV | May 16, 2012 | Abandoned |
Array
(
[id] => 9561880
[patent_doc_number] => 20140179594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR TREATMENT OF GRAM POSITIVE BACTERIA IN COMPANION ANIMALS AND LIVESTOCK'
[patent_app_type] => utility
[patent_app_number] => 14/112975
[patent_app_country] => US
[patent_app_date] => 2012-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 32006
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112975
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112975 | STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR TREATMENT OF GRAM POSITIVE BACTERIA IN COMPANION ANIMALS AND LIVESTOCK | Apr 19, 2012 | Abandoned |
Array
(
[id] => 9294114
[patent_doc_number] => 20140037748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'REDOX RESPONSIVE POLYMERIC NANOCAPSULES FOR PROTEIN DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 14/110058
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16418
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110058
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/110058 | REDOX RESPONSIVE POLYMERIC NANOCAPSULES FOR PROTEIN DELIVERY | Apr 12, 2012 | Abandoned |
Array
(
[id] => 8482848
[patent_doc_number] => 20120282255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALCOHOLISM AND ALCOHOL DEPENDENCE'
[patent_app_type] => utility
[patent_app_number] => 13/441337
[patent_app_country] => US
[patent_app_date] => 2012-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29470
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13441337
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/441337 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALCOHOLISM AND ALCOHOL DEPENDENCE | Apr 5, 2012 | Abandoned |
Array
(
[id] => 9293980
[patent_doc_number] => 20140037614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'THERAPEUTIC AND PROPHYLACTIC METHODS, USES AND COMPOSITIONS COMPRISING ANEXIN A5'
[patent_app_type] => utility
[patent_app_number] => 14/110176
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7408
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110176
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/110176 | THERAPEUTIC AND PROPHYLACTIC METHODS, USES AND COMPOSITIONS COMPRISING ANEXIN A5 | Apr 4, 2012 | Abandoned |
Array
(
[id] => 8406397
[patent_doc_number] => 20120238465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-20
[patent_title] => 'DRUG SCREENING TARGET FOR ALZHEIMER\'S DISEASE AND METHOD OF SCREENING POTENTIAL DRUGS'
[patent_app_type] => utility
[patent_app_number] => 13/423239
[patent_app_country] => US
[patent_app_date] => 2012-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18497
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13423239
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/423239 | DRUG SCREENING TARGET FOR ALZHEIMER'S DISEASE AND METHOD OF SCREENING POTENTIAL DRUGS | Mar 17, 2012 | Abandoned |
Array
(
[id] => 10038233
[patent_doc_number] => 09078928
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-14
[patent_title] => 'Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanionic polypeptide for the treatment of AIDS'
[patent_app_type] => utility
[patent_app_number] => 14/005688
[patent_app_country] => US
[patent_app_date] => 2012-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 5
[patent_no_of_words] => 11508
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14005688
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/005688 | Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanionic polypeptide for the treatment of AIDS | Mar 15, 2012 | Issued |
Array
(
[id] => 10038233
[patent_doc_number] => 09078928
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-14
[patent_title] => 'Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanionic polypeptide for the treatment of AIDS'
[patent_app_type] => utility
[patent_app_number] => 14/005688
[patent_app_country] => US
[patent_app_date] => 2012-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 5
[patent_no_of_words] => 11508
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14005688
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/005688 | Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanionic polypeptide for the treatment of AIDS | Mar 15, 2012 | Issued |
Array
(
[id] => 9041594
[patent_doc_number] => 20130244232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'HIGH-EFFICIENCY CATALYSTS, PREPARATION AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/421340
[patent_app_country] => US
[patent_app_date] => 2012-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13653
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13421340
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/421340 | HIGH-EFFICIENCY CATALYSTS, PREPARATION AND USE THEREOF | Mar 14, 2012 | Abandoned |
Array
(
[id] => 10600255
[patent_doc_number] => 09320803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-26
[patent_title] => 'Bisphosphonate-prodrugs'
[patent_app_type] => utility
[patent_app_number] => 14/001387
[patent_app_country] => US
[patent_app_date] => 2012-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 8221
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14001387
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/001387 | Bisphosphonate-prodrugs | Feb 23, 2012 | Issued |